Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Public ClinicalTrials.gov record NCT01192503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01192503
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- University of Virginia
- Other
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Interventions
- rasagiline Drug
- placebo (sugar pill) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2010
- Primary completion
- May 31, 2012
- Completion
- Jul 31, 2012
- Last update posted
- Feb 10, 2013
2010 – 2012
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advent Research | Pinellas Park | Florida | 33781 | — |
| Medical College of Georgia Movements Disorders Program | Augusta | Georgia | 30912 | — |
| Northwestern University PD and Movement Disorders Center | Chicago | Illinois | 60611 | — |
| Atlantic Neuroscience Institute Overlook Hospital | Summit | New Jersey | 07902 | — |
| SUNY- Buffalo Jacobs Neurological Institute | Buffalo | New York | 14203 | — |
| Cleveland Clinic Sleep Disorders Center | Cleveland | Ohio | 44195 | — |
| University of Pennsylvania Sleep Center | Philadelphia | Pennsylvania | 19104 | — |
| Charlottesville Medical Research | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01192503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01192503 live on ClinicalTrials.gov.